Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737977) titled 'Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738016) titled 'Artificially Intelligent Robotic Control' on July 27. Study Type: Intervention... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738276) titled 'Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist,... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738393) titled 'In-Person, Online, and Hybrid Healthy-Aging Education for Pre-Frailty and Frail... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738432) titled 'Neuro-MoD: Neuroplasticity With Motor Development' on July 27. Study Type: Int... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738731) titled 'Dialysis Less Frequently in the Elderly' on July 27. Study Type: Interventiona... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738887) titled 'Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07740577) titled 'Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Se... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738419) titled 'Diagnostic Accuracy of a Deep Learning-Based Software for Automated Multiparame... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738510) titled 'Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplas... Read More